ApprovalTrail

Drug · DIN 02221926

TOPICORT

Yes: authorized and sold in Canada

Authorized, and the company reports that it sells it in Canada.

Status Marketed since October 19, 2020; first marketed December 4, 1996.
Drug Identification Number (DIN)
02221926
Company (DIN owner)
Bausch Health, Canada Inc.Laval, Quebec, Canada
Schedule
Prescription
Dosage form
Gel
Route
Topical
Therapeutic class (ATC)
Desoximetasone D07AC03
Class
Human
Record last updated
December 23, 2025

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
DESOXIMETASONE0.05 %

Notices of Compliance

Health Canada approvals that name this DIN.

Other DINs named TOPICORT